References
- EtheridgeMLCampbellSAErdmanAGHaynesCLWolfSMMcCulloughJThe big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine20139111422684017
- HorstkotteEOdoerferKITowards improved therapies using nanopharmaceuticals: recent patents on pharmaceutical nanoformulationsRecent Pat Food Nutr Agric20124322024423013408
- Fernandez-FernandezAManchandaRMcGoronAJTheranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platformsAppl Biochem Biotechnol20111657–81628165121947761
- HallJBDobrovolskaiaMAPatriAKSMcNeilSECharacterization of nanoparticles for therapeuticsNanomedicine20072678980318095846
- KatebBChiuKBlackKLNanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Neuroimage201154suppl 1S106S12420149882
- BenezraMPenate-MedinaOZanzonicoPBMultimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanomaJ Clin Invest201112172768278021670497
- LibuttiSKPaciottiGFByrnesAAPhase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicineClin Cancer Res201016246139614920876255
- DemoyMAndreuxJPWeingartenCGouritinBGuillouxVCouvreurPSpleen capture of nanoparticles: influence of animal species and surface characteristicsPharm Res199916137419950276
- ChoWSChoMJeongJAcute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticlesToxicol Appl Pharmacol20092361162419162059
- De JongWHHagensWHKrystekPBurgerMCSipsAJAMGeertsmaREParticle size-dependent organ distribution of gold nanoparticles after intravenous administrationBiomaterials200829121912191918242692
- HirnSSemmler-BehnkeMSchlehCParticle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEur J Pharm Biopharm201177340741621195759
- VirellaGDiagnostic evaluation of phagocytic functionVirellaGImmunology Series58New YorkMarcel Dekker1993311327
- CampbellPAVanonoBPDrevetsDAMeasurement of bacterial ingestion and killing by macrophagesCollganJEKruisbeckAMMarguliesDHShevachEMStroberWCurrent Protocols in ImmunologyNew YorkJohn Wiley & Sons, Inc199414.6.114.6.13
- SkoczenSLPotterTMDobrovolskaiaMAIn vitro analysis of nanoparticle uptake by macrophages using chemiluminescenceMcNeilSECharacterization of Nanoparticles Intended for Drug DeliveryNew YorkSpringer Science2011255261
- Braydich-StolleLKSpeshockJLCastleASmithMMurdockRCHussainSMNanosized aluminum altered immune functionACS Nano2010473661367020593840
- ShvedovaAAFabisiakJPKisinERSequential exposure to carbon nanotubes and bacteria enhances pulmonary inflammation and infectivityAm J Respir Cell Mol Biol200838557959018096873
- MitchellLALauerFTBurchielSWMcDonaldJDMechanisms for how inhaled multiwalled carbon nanotubes suppress systemic immune function in miceNat Nanotechnol20094745145619581899
- ZogovicNSNikolicNSVranjes-DjuricSDOpposite effects of nanocrystalline fullerene (C(60)) on tumour cell growth in vitro and in vivo and a possible role of immunosupression in the cancer-promoting activity of C(60)Biomaterials200930366940694619781768
- MoonEYYiGHKangJSLimJSKimHMPyoSAn increase in mouse tumor growth by an in vivo immunomodulating effect of titanium dioxide nanoparticlesJ Immunotoxicol201181566721288165
- Guidance for Industry. S8 Immunotoxicity Studies for Human Pharmaceuticals2006 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm074965.pdf
- BancosSWeaverJLKatherine TynerKMEvaluation of viability and proliferation profiles of macrophage-treated silica nanoparticles in vitro via plate based, flow cytometry and Coulter counter assaysISRN Nanotechnol20122012 Article ID 454072:11
- KeeneAMTynerKMAnalytical characterization of gold nanoparticle primary particles, aggregates, agglomerates, and agglomerated aggregatesJ Nanopart Res20111334653481
- KeeneAMPetersDRouseRStewartSRosenETTynerKMTissue and cellular distribution of gold nanoparticles varies based on aggregation/agglomeration statusNanomedicine20127219920922339133
- National Research CouncilGuide for the Care and Use of Laboratory AnimalsWashington, DC, USANational Academy Press1996
- ThakorASLuongRPaulmuruganRThe fate and toxicity of Raman-active silica-gold nanoparticles in miceSci Transl Med201137979ra33
- GoelRShahNVisariaRPaciottiGFBischofJCBiodistribution of TNF-alpha-coated gold nanoparticles in an in vivo model systemNanomedicine20094440141019505243
- MukherjeePAntiangiogenic properties of gold nanoparticlesClin Cancer Res2005113530353415867256
- WarheitDBHow meaningful are the results of nanotoxicity studies in the absence of adequate material characterizationToxicol Sci2008101218318518300382
- OberdorsterGSafety assessment for nanotechnology and nanomedicine: concepts of nanotoxicologyJ Intern Med200926718910520059646
- TeeguardenJGHinderliterPMOrrGThrallBDPoundsJGParticokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessmentsToxicol Sci200695230031217098817
- UlevitchRJTobiasPSReceptor dependent mechanism of cell stimulation by bacterial endotoxinAnnu Rev Immunol1995134374577542010
- LichtmanSNWangJLemastersJJLPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cellsAm J Physiol19982751G39G469655682
- NeteaMGKullbergBJvan der MeerJWLipopolysaccharide-induced production of tumor necrosis factor and interleukin-1 is differentially regulated at the receptor level: the role of CD-14-dependent and CD-14-independent pathwaysImmunology19989433403439767415
- JianZJYangZMillerMSCarterCDSlausonDOBochslerPNInterleukin-6 secretion by bacterial lipopolysaccharide-stimulated bovine alveolar macrophages in vitroVet Immunol Immunopathol1995491–251608588344
- ZhangQHitchinsVMSchrandAMHussainSMGoeringPUptake of gold nanoparticles in murine macrophage cells without cytotoxicity or production of pro-inflammatory mediatorsNanotoxicology20115328429520849214
- KusakaTNakayamaMNakamuraKIshimiyaMFurusawaEOgasawaraKEffect of silica particle size on macrophage inflammatory responsesPLoS One201493e9263424681489
- GosensIPostJAde la FonteyneLJJImpact of agglomeration state of nano- and submicron sized gold particles on pulmonary inflammationPart Fibre Toxicol201073711120180970
- LeeJYParkWYiDKImmunostimulatory effects of gold nanorod and silica-coated gold nanorod on RAW 264.7 mouse macrophagesToxicol Lett20122091515722155353
- KimSOhWKJeongYSCytotoxicity of, and innate immune response to, size-controlled polypyrrole nanoparticles in mammalian cellsBiomaterials201132922342250
- KimJSAdamcakova-DoddAO’ShaughnessyPTGrassianVHThornePSEffects of copper nanoparticle exposure on host defense in a murine pulmonary infection modelPart Fibre Toxicol20118294321943386
- DeicherRXiaiFCohenGMullnerMHorlWHHigh-dose parenteral iron sucrose depresses neutrophil intracellular killing capacityKidney Int20036472873612846772
- DanikasKKKarakantzaMTheodorousGLSakellaropoulosGCGogosCAPrognostic value of phagocytic activity of neutrophils and monocytes in sepsis. Correlation to CD64 and CD14 antigen expressionClin Exp Immunol20081541879718727624
- PrietoJSubiraMLVastillaACiveiraMPSerranoMMonocyte disorder causing cellular immunodeficiency: a family studyClin Exp Immunol1990791162302828
- WolachBGavrieliRRoosDBerger-AchituvSLessons learned from phagocytic function studies in a large cohort of patients with recurrent infectionsJ Clin Immunol201232345446622207252
- SharbaughRJEffect of cyclophosphamide on in vitro phagocytosis of staphylococcus aureusJ Infect Dis197613466196231003015
- CoraschiDConstantinoLItalianiPInteraction of nanoparticles with immunocompetent cells: nanosafety considerationsNanomedicine201271212113122191781
- QuGZhangCYuanLQuantum dots impair macrophagic morphology and the ability of phagocytosis by inhibiting the Rho-associated kinase signalingNanoscale201242239224422395807
- RenwickLCBrownDClouterADonaldsonKIncreased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle typesOccup Environ Med200461544244715090666
- LiuHYangDYangHComparative study of respiratory tract immune toxicity induced by three sterilisation nanoparticles: silver, zinc oxide and titanium dioxideJ Hazard Mater2013248–249478486
- KodaliVLittkeMHTiltonSCDysregulation of macrophage activation profiles by engineered nanoparticlesACS Nano2013786997701023808590